Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation

NCT01836341 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Afatinib
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Pemetrexed
RADIATION: Radiation therapy

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]